Trulieve Cannabis Corp. (TRLV) is a prominent player in the US cannabis market, distinguished by its comprehensive vertical integration that encompasses cultivation, production, and retail distribution of cannabis products. With a significant presence in critical states like Florida, Trulieve is dedicated to delivering high-quality and innovative solutions that cater to a diverse consumer base. The company’s robust commitment to community involvement and sustainable business practices not only enhances its brand reputation but also positions Trulieve strategically for long-term growth amidst the dynamic landscape of the cannabis industry.
| Revenue (TTM) | $1.14B |
| Gross Profit (TTM) | $677.39M |
| EBITDA | $301.02M |
| Operating Margin | 12.80% |
| Return on Equity | -47.60% |
| Return on Assets | 3.28% |
| Revenue/Share (TTM) | $5.93 |
| Book Value | $6.07 |
| Price-to-Book | 2.42 |
| Price-to-Sales (TTM) | 1.60 |
| EV/Revenue | 1.851 |
| EV/EBITDA | 6.07 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.30% |
| Shares Outstanding | $169.98M |
| Float | $167.89M |
| % Insiders | 1.34% |
| % Institutions | 20.80% |
TALLAHASSEE, Fla., Aug. 18, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., announced it will ring The Closing Bell® at the New York Stock Exchange (NYSE) at 4:00 P.M.
What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US, what happens at the federal level has moved the needle the most, with the recent passing of legislation to reclassify cannabis to Schedule 3.
TALLAHASSEE, Fla., Aug. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the completion of its previously announced plan to redomicile Trulieve Cannabis Corp. from British Columbia, Canada to Delaware, United States.
Trulieve Cannabis (TRLV) is the first U.S. cannabis operator to uplist to the NYSE, unlocking broader investor access and liquidity. Recent catalysts include a $50 million share repurchase program and a profitable Q1 2026 with $42 million in free cash flow. Reclassification of medical marijuana to Schedule III removes the 280E tax burden, providing a major earnings and cash flow tailwind for TRLV.
Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call Transcript
Second quarter revenue of $271 million, with 60% gross margin Cash flow from operations of $109 million and free cash flow of $74 million* in first half of 2026 First U.S. Cannabis Company listed on New York Stock Exchange under ticker "TRLV" TALLAHASSEE, Fla., Aug. 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TR LV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced its results for the quarter ended June 30, 2026.
TALLAHASSEE, Fla., Aug. 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced planned event participation in August.
New Collier County location will host grand opening celebration Friday, July 24 TALLAHASSEE, Fla., July 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Marco Island, Florida.
TALLAHASSEE, Fla., July 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., will hold a conference call on Friday, August 7, 2026 at 8:30 AM Eastern Time following the release of its second quarter 2026 financial results.
TALLAHASSEE, Fla., July 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that it has been named to TIME's list of America's Best Companies 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TRLV and any ticker you trade — then tracks every position and per-strategy win rate.
